USA's AARP and health publication collaborate to create on-line tool to help consumers to manage drug decisions

12 November 2010

To help US consumers better understand prescription drug choices, the seniors organization AARP and Consumer Reports Health have launched a new on-line drug comparison tool. For the first time, they claim, people can use Consumers Union data to compare prescription drug safety, effectiveness, convenience and price, as well as receive tips on how to have a conversation about their medications with their doctor or pharmacist - all at one easy-to-use web site.

"We know that consumers want trustworthy, independent information on prescription drugs so they can make informed decisions about what is best for their health and the health of their family," said Bob Gallo, AARP Illinois state director, adding: "This tool will be especially valuable to our membership and will help all users better manage their prescriptions."

The AARP Drug Savings Tool (available at drugsavings.aarp.org) allows users to select the drug they want to compare from Consumer Reports Health's database of about 500 drugs in 26 drug classes. The tool then provides consumers with the "Best Buy" recommendations - drugs that are recommended by Consumer Reports Health Best Buy Drugs project based on their safety, effectiveness, cost and convenience. Users are also provided with a discussion sheet to help guide related conversations with their doctor, pharmacist or other health care professional Finally, consumers can access the complete Consumer Reports Health Best Buy Drugs reports on each topic.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical